We are live on ! Find out more
BIVI icon

BioVie
BIVI

39 hedge funds and large institutions have $9.5M invested in BioVie in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 1

694% more capital invested

Capital invested by funds: $1.2M → $9.5M (+$8.3M)

525% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 4

117% more funds holding

Funds holding: 18 → 39 (+21)

0.02% more ownership

Funds ownership: 0.02% → 0.04% (+0.02%)

Holders
39
Holders Change
+21
Holders Change %
+116.67%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
11
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.48M
2
S
swisspartners
Liechtenstein
+$721K
3
Millennium Management
Millennium Management
New York
+$682K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$201K
5
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$160K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$244K
2
PVI
Pura Vida Investments
New York
-$91K
3
HF
HRT Financial
New York
-$43K
4
TRCT
Tower Research Capital (TRC)
New York
-$30.8K
5
LPL Financial
LPL Financial
California
-$25K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$2.31M +$1.48M +2,738 +1,165%
S
2
swisspartners
Liechtenstein
$2.29M +$721K +1,333 +83%
Millennium Management
3
Millennium Management
New York
$981K +$682K +1,262 New
Geode Capital Management
4
Geode Capital Management
Massachusetts
$595K +$201K +372 +94%
Vanguard Group
5
Vanguard Group
Pennsylvania
$337K +$46K +85 +24%
BlackRock
6
BlackRock
New York
$272K +$140K +259 +285%
SKK
7
Shepherd Kaplan Krochuk
Massachusetts
$229K +$160K +295 New
Barclays
8
Barclays
United Kingdom
$193K +$135K +249 New
Morgan Stanley
9
Morgan Stanley
New York
$174K +$109K +202 +962%
State Street
10
State Street
Massachusetts
$157K +$27.6K +51 +34%
LFCM
11
Long Focus Capital Management
Puerto Rico
$155K – – –
Bank of America
12
Bank of America
North Carolina
$143K +$100K +185 New
Man Group
13
Man Group
United Kingdom
$143K +$98.9K +183 New
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$134K +$93K +172 New
GC
15
Garde Capital
Washington
$133K +$93K +172 New
6CM
16
683 Capital Management
New York
$125K +$87K +161 New
SSA
17
Schonfeld Strategic Advisors
New York
$120K +$83.8K +155 New
Citadel Advisors
18
Citadel Advisors
Florida
$118K +$82.2K +152 New
FIA
19
FNY Investment Advisers
New York
$110K +$76.8K +142 New
EGM
20
Engineers Gate Manager
New York
$102K +$70.8K +131 New
Northern Trust
21
Northern Trust
Illinois
$98.1K +$68.1K +126 New
Commonwealth Equity Services
22
Commonwealth Equity Services
Massachusetts
$94K +$66K +122 New
BFM
23
Boothbay Fund Management
New York
$88.4K +$61.6K +114 New
IAIM
24
International Assets Investment Management
Florida
$81.6K +$56.8K +105 New
Bank of Montreal
25
Bank of Montreal
Ontario, Canada
$77.8K +$54.1K +100 New
1
2

BIVI Hedge Fund Activity: Q4 2022 in Review

39 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q4 2022, worth a combined $9.5M — up 694% from $1.2M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BIVI positions and 4 closed out — a net gain of 21 holders — while 11 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.48M. The largest seller was Sabby Management, exiting entirely with an estimated $244K sold.

  • 39 institutional investors held BioVie (BIVI) as of Q4 2022, up from 18 in Q3 2022.
  • Funds reported $9.5M of BioVie stock for Q4 2022, up 694% quarter-over-quarter.
  • 25 funds opened new BioVie positions in Q4 2022 and 4 closed out, a net change of +21 holders.
  • The largest BioVie buyer in Q4 2022 was Renaissance Technologies, an estimated $1.48M added.
  • The largest BioVie seller in Q4 2022 was Sabby Management, an estimated $244K sold.

Based on aggregated 13F filings for Q4 2022.